##  [Novartis drug Promacta® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)](/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0 "Novartis drug Promacta® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)") 

  Oct 18, 2017